Medical Device Network
Neurogen Biomarking has announced a collaboration with American TelePhysicians’ venture NeuroX to support patients’ journey on its brain health care ecosystem, which expedites access to early Alzheimer’s dementia and Mild Cognitive Impairment (MCI) detection technology. Neurogen is offering virtual neurology services in this regard. This collaboration aims to transform the early identification of Alzheimer’s disease (AD) via accessible blood biomarker testing and AI-powered digital assessments. NeuroX’s neurologists will provide support to suitable patients of Neurogen through telehealth, offering follow-up care and expediting cognitive care access.
See full story at Medical Device Network
Sign up for our newsletter!
Get the latest information and inspirational stories for caregivers, delivered directly to your inbox.